Varex Imaging Corporation logo
Varex Imaging Corporation VREX
$ 10.82 1.5%

Quarterly report 2025-Q4
added 02-10-2026

report update icon

Varex Imaging Corporation Income Statement 2011-2026 | VREX

Annual Income Statement Varex Imaging Corporation

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

502 M 577 M 752 M 889 M 1.24 B 621 M 1.12 B 947 M 1.28 B - - - - - -

Shares

41.4 M 40.8 M 40.3 M 39.8 M 39.3 M 38.8 M 38.6 M 38.4 M 38 M - - - - - -

Historical Prices

12.1 14.1 18.6 22.3 31.6 16.7 29.8 23.7 40.2 - - - - - -

Net Income

-70.3 M -48.8 M 47.4 M 30.3 M 17.4 M -57.9 M 15.5 M 27.5 M 51.6 M 68.5 M 80 M 110 M 110 M - -

Revenue

845 M 811 M 893 M 859 M 818 M 738 M 781 M 773 M 698 M 620 M 632 M 685 M 670 M - -

Cost of Revenue

554 M 554 M 603 M 576 M 547 M 548 M 524 M 520 M 445 M 372 M 382 M - - - -

Gross Profit

290 M 257 M 290 M 284 M 272 M 190 M 257 M 254 M 254 M 248 M 251 M 279 M 268 M - -

Operating Income

-27.8 M 32.1 M 77.1 M 88.2 M 74.1 M -33.7 M 45.7 M 44.5 M 83.7 M 109 M 128 M - - - -

Interest Expense

-4.4 M -4.2 M -20.2 M -4.3 M 42.1 M 31.4 M 21.1 M 21.7 M 12.3 M 1.9 M 1.2 M - - - -

EBITDA

-4.6 M 53.3 M 96.6 M 107 M 94.6 M -11.4 M 84.9 M 86.7 M 111 M 124 M 140 M 186 M 179 M - -

Operating Expenses

318 M 225 M 213 M 195 M 197 M 224 M 211 M 209 M 170 M 139 M 123 M 103 M 99.3 M - -

General and Administrative Expenses

133 M 138 M 128 M 118 M 126 M 142 M 128 M 126 M 102 M 85.8 M - - - - -

All numbers in USD currency

Quarterly Income Statement Varex Imaging Corporation

2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

41.8 M 41.7 M 41.5 M 41.4 M 41.1 M 41.1 M 40.9 M 40.7 M 40.6 M 40.5 M 40.4 M 40.2 M 40.1 M 40.1 M 39.9 M 39.7 M 39.5 M 39.4 M 39.4 M 39.2 M 38.5 M 38.7 M 39 M 38.6 M - 38.2 M 38.3 M 38.2 M 38.1 M 37.8 M 37.9 M 38.1 M 37.7 M 37.5 M 37.6 M 37.7 M 37.4 M 37.4 M 37.4 M 37.4 M - - - - - - - - - - - - - - - - - - - -

Net Income

2.3 M - -89.1 M 6.9 M -300 K - 1.4 M 1.4 M -500 K - 9.1 M 4.1 M 3.1 M - 8.2 M 7.6 M 1.4 M - 12 M 3.1 M -1.3 M -31.5 M -28.3 M -1.9 M - 7.4 M -1.4 M 5.8 M 3 M 27.5 M 3.8 M 3 M 11.3 M 36.8 M 10.6 M 11.3 M 11.1 M 46.5 M 17.6 M 11.1 M - - - - - - - - - - - - - - - - - - - -

Revenue

210 M - 203 M 213 M 200 M - 209 M 206 M 190 M - 232 M 228 M 206 M - 214 M 215 M 199 M - 211 M 204 M 200 M 568 M 171 M 197 M - 578 M 197 M 196 M 186 M 569 M 191 M 201 M 176 M 482 M 170 M 155 M 157 M 448 M 151 M 157 M - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

140 M - 136 M 136 M 131 M - 142 M 140 M 133 M - 156 M 156 M 142 M - 141 M 144 M 134 M - 137 M 139 M 139 M 423 M 145 M 139 M - 393 M 136 M 131 M 126 M 374 M 128 M 131 M 115 M 307 M 111 M 97.2 M 98.6 M 269 M 88.4 M 98.6 M - - - - - - - - - - - - - - - - - - - -

Gross Profit

69.8 M - 67.5 M 76.7 M 68.5 M - 66.9 M 65.8 M 57.1 M - 76.3 M 72.7 M 63.3 M - 73.4 M 70.8 M 64.8 M - 74.1 M 64.6 M 61.1 M 145 M 26.3 M 57.6 M - 185 M 60.7 M 64.4 M 60 M 195 M 63 M 60 M 61.5 M 176 M 59.5 M 61.5 M 58.8 M 179 M 63 M 58.8 M - - - - - - - - - - - - - - - - - - - -

Operating Income

15.4 M - -80.7 M 22.1 M 11.2 M - 9.3 M 7.7 M 4.2 M - 24.2 M 15.6 M 13 M - 23 M 26.6 M 14 M - 25.7 M 15.8 M 4.6 M -20.8 M -26.8 M 1.4 M - 29.5 M 4.6 M 14.5 M 10.4 M 38.1 M 7.3 M 10.4 M 13.6 M 57.1 M 15.5 M 13.6 M 18.6 M 76.1 M 28.4 M 18.6 M - - - - - - - - - - - - - - - - - - - -

Interest Expense

-4.3 M - 1 M -4 M -2.8 M - -2.9 M 700 K 600 K - -700 K 7.3 M 7.5 M - 9.4 M 11.1 M 9.9 M - 10.6 M 10.4 M 5.4 M 16.9 M 6.9 M 4.6 M - 15.7 M 5.1 M 5.5 M 5.1 M 16.5 M 5.4 M 5.1 M 5.5 M 5.8 M 4.2 M 5.5 M 600 K 1.3 M 400 K 600 K - - - - - - - - - - - - - - - - - - - -

EBITDA

21.1 M - -79.7 M 23.1 M 17.4 M - 11 M 11.3 M 9.3 M - 27.6 M 19 M 17.6 M - 26.7 M 30.3 M 18.8 M - 36.2 M 20.1 M 9.8 M -3.5 M -15.4 M 5.8 M - 48.2 M 18.7 M 18.1 M 20.2 M 54.1 M 17.8 M 20.2 M 18.5 M 67.7 M 24 M 18.5 M 21.7 M 83.3 M 32.8 M 21.7 M - - - - - - - - - - - - - - - - - - - -

Operating Expenses

54.4 M - 148 M 54.6 M 57.3 M - 57.6 M 58.1 M 52.9 M - 52.1 M 57.1 M 50.3 M - 50.4 M 44.2 M 50.8 M - 48.4 M 48.8 M 56.5 M 166 M 53.1 M 56.2 M - 156 M 56.1 M 49.9 M 49.6 M 157 M 55.7 M 49.6 M 47.9 M 119 M 44 M 47.9 M 40.2 M 103 M 34.6 M 40.2 M - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

32.7 M - 32.9 M 32.6 M 33.8 M - 35.6 M 35.5 M 32.4 M - 32.1 M 34.1 M 30.3 M - 30.2 M 25.3 M 33.1 M - 29.2 M 30.6 M 34.8 M 102 M 31.4 M 35.3 M - 92.3 M 31.2 M 30.3 M 30.8 M 94.3 M 35.2 M 30.8 M 28.2 M 73.3 M 26.3 M 28.2 M 26.9 M 63.5 M 20.6 M 26.9 M - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

The income statement is one of the three key financial reports of a company Varex Imaging Corporation (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:

  • How much revenue the company earned
  • How much it spent on production, personnel, marketing, taxes, etc.
  • What profit remained in the end

Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.

Features
  • The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
  • Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
  • A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.

Reports on the profits and losses of other stocks in the Medical devices industry

Issuer Price % 24h Market Cap Country
Butterfly Network Butterfly Network
BFLY
$ 4.19 5.67 % $ 887 M usaUSA
InMode Ltd. InMode Ltd.
INMD
$ 13.73 1.48 % $ 887 M israelIsrael
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
- - $ 1.77 B usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
- - $ 3.31 B usaUSA
Lianluo Smart Limited Lianluo Smart Limited
LLIT
- 24.59 % $ 44.8 M chinaChina
Aziyo Biologics Aziyo Biologics
AZYO
- 1.37 % $ 20.5 M usaUSA
Acutus Medical Acutus Medical
AFIB
- -26.83 % $ 2.62 M usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
- 3.58 % $ 2.21 M usaUSA
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
- -5.86 % $ 30.6 M usaUSA
Bruker Corporation Bruker Corporation
BRKR
$ 34.86 4.68 % $ 5.19 K usaUSA
BioSig Technologies BioSig Technologies
BSGM
- 37.08 % $ 85.7 M usaUSA
Conformis Conformis
CFMS
- - $ 16.4 M usaUSA
ClearPoint Neuro ClearPoint Neuro
CLPT
$ 9.51 5.32 % $ 269 M usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
- 0.15 % $ 844 M usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
- - $ 475 M usaUSA
Alphatec Holdings Alphatec Holdings
ATEC
$ 12.15 -1.78 % $ 1.82 B usaUSA
Delcath Systems Delcath Systems
DCTH
$ 9.1 0.33 % $ 326 M usaUSA
Avinger Avinger
AVGR
- -20.74 % $ 369 K usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
- -4.14 % $ 702 M usaUSA
CHF Solutions, Inc. CHF Solutions, Inc.
CHFS
- 1.15 % $ 34.5 M usaUSA
AxoGen AxoGen
AXGN
$ 31.75 3.15 % $ 1.46 B usaUSA
Establishment Labs Holdings Establishment Labs Holdings
ESTA
$ 59.61 -4.85 % $ 1.77 B costa-ricaCosta-rica
CONMED Corporation CONMED Corporation
CNMD
$ 36.63 1.92 % $ 1.14 B usaUSA
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
EW
$ 82.02 -0.58 % $ 48 B usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
- -1.42 % $ 435 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
- -1.98 % $ 98.3 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
- 0.03 % $ 1.58 B israelIsrael
Electromed Electromed
ELMD
$ 24.49 5.2 % $ 207 M usaUSA
Misonix, Inc. Misonix, Inc.
MSON
- - $ 462 M usaUSA
Neovasc Neovasc
NVCN
- - $ 111 M canadaCanada
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
- - $ 955 M usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
$ 0.67 2.06 % $ 36.5 M usaUSA
Aethlon Medical Aethlon Medical
AEMD
$ 2.3 6.48 % $ 3.59 M usaUSA
BIOLASE BIOLASE
BIOL
- -13.19 % $ 166 K usaUSA
Helius Medical Technologies Helius Medical Technologies
HSDT
$ 2.06 0.98 % $ 1.25 M usaUSA
Integra LifeSciences Holdings Corporation Integra LifeSciences Holdings Corporation
IART
$ 9.43 5.48 % $ 726 M usaUSA
AdaptHealth Corp. AdaptHealth Corp.
AHCO
$ 10.37 4.64 % $ 1.4 B usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
$ 1.35 - $ 21.8 M usaUSA
IRadimed Corporation IRadimed Corporation
IRMD
$ 99.2 -0.3 % $ 1.26 B usaUSA
FONAR Corporation FONAR Corporation
FONR
$ 18.34 -0.22 % $ 120 M usaUSA
Invacare Corporation Invacare Corporation
IVC
- - $ 24.7 M usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
$ 3.73 3.32 % $ 139 M franceFrance
OrthoPediatrics Corp. OrthoPediatrics Corp.
KIDS
$ 16.47 -0.3 % $ 386 M usaUSA
Inspire Medical Systems Inspire Medical Systems
INSP
$ 52.16 -2.9 % $ 1.53 B usaUSA
LivaNova PLC LivaNova PLC
LIVN
$ 63.24 1.69 % $ 3.45 B britainBritain
Medtronic PLC Medtronic PLC
MDT
$ 87.17 1.13 % $ 112 B usaUSA
Pulmonx Corporation Pulmonx Corporation
LUNG
$ 1.39 2.21 % $ 56.6 M usaUSA
Cutera Cutera
CUTR
- -10.19 % $ 1.99 M usaUSA
Myomo Myomo
MYO
$ 0.71 0.08 % $ 29.7 M usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
- 14.99 % $ 929 K usaUSA